• Lactobacillus gasseri Regulates E-cadherin to Alleviate Coli

  2026-06-25

  The referenced study identifies a novel mechanism by which Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis in mice through NR1I3-mediated regulation of E-cadherin. These findings clarify the probiotic's impact on the intestinal mucosal barrier and provide a mechanistic basis for targeted interventions in inflammatory bowel disease.

• Ciclesonide in Translational Asthma Research: Protocols & In

  2026-06-25

  Ciclesonide’s targeted lung activation and potent glucocorticoid receptor binding make it a standout tool for asthma and allergic rhinitis research. This article delivers actionable workflows, advanced troubleshooting, and the latest innovations in targeted protein degradation, helping researchers elevate respiratory models with APExBIO’s high-purity compound.

• 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB): Precisi

  2026-06-24

  Explore how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) enables fine-tuned inhibition of RNA polymerase II and cyclin-dependent kinases, with new insight into cell fate modulation. This article uniquely bridges molecular mechanism, assay optimization, and translational perspectives.

• Staurosporine (SKU A8192): Reliable Kinase Inhibition in Can

  2026-06-23

  This article provides a scenario-driven guide to overcoming common challenges in cell viability and apoptosis assays using Staurosporine (SKU A8192). Drawing on validated protocols, quantitative kinase inhibition data, and real-world workflow considerations, it empowers biomedical researchers with best practices for reproducibility, sensitivity, and practical laboratory implementation. Discover how APExBIO’s Staurosporine enables robust, data-backed experimental outcomes.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Protocols & Q

  2026-06-23

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted protein degradation during extraction, especially in workflows sensitive to EDTA or requiring intact phosphorylation states. It is not suitable for applications where EDTA is required as a chelator, nor does it replace the need for careful sample handling and cold-chain maintenance.

• Budesonide in Translational Inflammation Models: Permeabilit

  2026-06-22

  Explore Budesonide as a potent anti-inflammatory corticosteroid in the context of advanced pulmonary permeability modeling and translational inflammation research. This article reveals new assay strategies and deeper mechanistic insights, setting a benchmark for respiratory disease research.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-06-22

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody is designed for sensitive and specific detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and fluorescence microscopy. It should not be used with non-rabbit primary antibodies or in workflows incompatible with sodium azide, and demands careful light and temperature control to preserve fluorescence.

• Cisapride (R 51619): Powering Cardiac Electrophysiology Rese

  2026-06-21

  Cisapride (R 51619) enables precise modeling of cardiac safety and arrhythmia mechanisms via its dual action on 5-HT4 and hERG channels. Learn how to optimize deep learning-enhanced iPSC-CM assays, troubleshoot solubility issues, and leverage validated protocols for reproducible, high-content phenotypic screening.

• 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB): Precisi

  2026-06-20

  Explore how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) enables precise inhibition of RNA polymerase II and advances RNA epitranscriptomics research. This article uniquely bridges transcriptional elongation control with emerging insights on ac4C-modified lncRNA regulation, offering actionable protocols and comparative analysis.

• Novobiocin Sodium: Beyond DNA Gyrase—New Horizons in Antipar

  2026-06-19

  Explore how Novobiocin Sodium, a potent aminocoumarin antibiotic, is reshaping advanced research in DNA replication, apoptosis, and emerging antiparasitic therapies. This article uncovers novel experimental insights and practical assay guidance distinct from traditional workflows.

• Fluorouracil (Adrucil): Scenario-Driven Solutions for Solid

  2026-06-19

  This article explores real-world experimental challenges in solid tumor research and demonstrates how Fluorouracil (Adrucil), SKU A4071, delivers reliable and reproducible results. Integrating evidence-based protocol advice and candid product comparisons, it highlights the strategic advantages of using validated reagents like APExBIO’s Fluorouracil (Adrucil) for cell viability and cytotoxicity assays.

• AURKB Inhibition in Pulmonary Hypertension: Transcriptomic I

  2026-06-18

  Lemay et al. (2025) identify Aurora kinase B (AURKB) as a critical driver of pulmonary arterial hypertension (PAH) pathology, demonstrating that its inhibition in pulmonary artery smooth muscle cells (PASMCs) can reverse pathological remodeling and improve hemodynamics in preclinical models. This integrated transcriptomic and preclinical approach offers a new avenue for precision targeting of vascular remodeling in PAH.

• 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole: Protocols and

  2026-06-18

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) offers precise transcriptional elongation inhibition for dissecting cyclin-dependent kinase-regulated pathways, antiviral mechanisms, and cell fate decisions. This guide details experimental workflows, troubleshooting, and innovations leveraging DRB, with insights from cutting-edge germline stem cell research.

• TNF-alpha Recombinant Murine Protein: Mechanism & Benchmarks

  2026-06-17

  TNF-alpha recombinant murine protein is a proven cytokine for apoptosis and inflammation research. This article details its mechanism, quantitative activity, and the latest evidence linking TNF-alpha signaling to transcription-independent cell death pathways. Benchmarks and protocols are provided for reproducible translational workflows.

• 4-Ethylphenyl Sulfate: Advanced Workflows for Biomarker Rese

  2026-06-17

  Leverage 4-ethylphenyl sulfate for cutting-edge gut-brain and renal biomarker studies with robust, reproducible workflows. This guide details experimental design, adsorption science, and troubleshooting strategies for maximizing insight from this unique microbiota-derived metabolite.

15584 records 1/1039 page Next 12345 下5页 Last page